WP
IBB icon

WealthSource Partners’s iShares Biotechnology ETF IBB Stock Holding History

WealthSource Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$440K Sell
3,236
-106
-3% -$12.9K 0.03% 352
2023
Q3 		$409K Sell
3,342
-5
-0.1% -$636 0.03% 352
2023
Q2 		$425K Hold
3,347
– – 0.03% 351
2023
Q1 		$432K Buy
3,347
+5
+0.1% +$655 0.03% 337
2022
Q4 		$439K Hold
3,342
– – 0.03% 325
2022
Q3 		$391K Sell
3,342
-50
-1% -$6.21K 0.03% 340
2022
Q2 		$399K Sell
3,392
-130
-4% -$15.4K 0.03% 342
2022
Q1 		$459K Buy
3,522
+546
+18% +$71.1K 0.03% 360
2021
Q4 		$454K Sell
2,976
-100
-3% -$15.5K 0.04% 327
2021
Q3 		$497K Hold
3,076
– – 0.04% 294
2021
Q2 		$503K Sell
3,076
-187
-6% -$28.8K 0.04% 272
2021
Q1 		$491K Hold
3,263
– – 0.05% 243
2020
Q4 		$494K Sell
3,263
-89
-3% -$12.7K 0.06% 212
2020
Q3 		$454K Sell
3,352
-108
-3% -$14.7K 0.06% 203
2020
Q2 		$473K Sell
3,460
-190
-5% -$24.2K 0.07% 194
2020
Q1 		$393K Sell
3,650
-1,935
-35% -$223K 0.06% 206
2019
Q4 		$673K Sell
5,585
-145
-3% -$16.2K 0.09% 181
2019
Q3 		$570K Sell
5,730
-625
-10% -$65.4K 0.09% 214
2019
Q2 		$693K Buy
6,355
+4,315
+212% +$459K 0.11% 180
2019
Q1 		$228K Sell
2,040
-70
-3% -$7.68K 0.05% 313
2018
Q4 		$203K Hold
2,110
– – 0.06% 283
2018
Q3 		$257K Buy
2,110
+60
+3% +$7.07K 0.07% 243
2018
Q2 		$225K Sell
2,050
-501
-20% -$53.6K 0.06% 258
2018
Q1 		$272K Sell
2,551
-8,710
-77% -$965K 0.08% 224
2017
Q4 		$1.2M Buy
11,261
+6,320
+128% +$676K 0.37% 64
2017
Q3 		$549K Sell
4,941
-24
-0.5% -$2.56K 0.18% 125
2017
Q2 		$513K Buy
+4,965
New +$489K 0.17% 128
2016
Q4 		– Sell
-2,670
Closed -$257K – 261
2016
Q3 		$257K Hold
2,670
– – 0.09% 201
2016
Q2 		$229K Buy
2,670
+168
+7% +$15.1K 0.09% 218
2016
Q1 		$218K Buy
+2,502
New +$224K 0.09% 203

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WealthSource Partners's IBB Position: Q4 2023 in Review

WealthSource Partners reduced its iShares Biotechnology ETF (IBB) stake by 3.2% in Q4 2023, selling an estimated $12.9K and leaving 3,236 shares worth $440K. The position accounts for 0.03% of the portfolio, ranked #352.

WealthSource Partners first reported a position in IBB in Q1 2016 and has held it in 30 quarters since. The position peaked at $1.2M in Q4 2017. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • WealthSource Partners held 3,236 shares of iShares Biotechnology ETF worth $440K as of Q4 2023.
  • WealthSource Partners sold 106 iShares Biotechnology ETF shares in Q4 2023, an estimated $12.9K.
  • iShares Biotechnology ETF made up 0.03% of WealthSource Partners's portfolio in Q4 2023, its #352 holding.
  • WealthSource Partners first reported a position in iShares Biotechnology ETF in Q1 2016 and has held it in 30 quarters since.
  • WealthSource Partners's iShares Biotechnology ETF position peaked at $1.2M in Q4 2017.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on WealthSource Partners's 13F filing for Q4 2023, filed 16 Jan 2024.